Reducing the risk of maternal-infant transmission of HIV: a door is opened

Editorial

M F Rogers et al. N Engl J Med. 1994.

. 1994 Nov 3;331(18):1222-3.

doi: 10.1056/NEJM199411033311810.

No abstract available

Comment on

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, et al. Connor EM, et al. N Engl J Med. 1994 Nov 3;331(18):1173-80. doi: 10.1056/NEJM199411033311801. N Engl J Med. 1994. PMID: 7935654 Clinical Trial.
A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
Spector SA, Gelber RD, McGrath N, Wara D, Barzilai A, Abrams E, Bryson YJ, Dankner WM, Livingston RA, Connor EM. Spector SA, et al. N Engl J Med. 1994 Nov 3;331(18):1181-7. doi: 10.1056/NEJM199411033311802. N Engl J Med. 1994. PMID: 7935655 Clinical Trial.